Moderna Inc. (MRNA) - 5i Research

Moderna Inc. (MRNA $27.63)
- $27.63 Cap: $10.86B
- View MRNA Profile
- View Questions on MRNA

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $295.32)
- $295.32 P/E (TTM): 24.15X Cap: $158.61B
- View AMGN Profile
- View Questions on AMGN
CVS Health Corporation (CVS $76.65)
- $76.65 P/E (TTM): 21.51X Cap: $97.57B
- View CVS Profile
- View Questions on CVS
Johnson & Johnson (JNJ $190.86)
- $190.86 P/E (TTM): 20.2X Cap: $456.83B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $96.64)
- $96.64 P/E (TTM): 27.16X Cap: $125.53B
- View MDT Profile
- View Questions on MDT
Moderna Inc. (MRNA $27.63)
- $27.63 Cap: $10.86B
- View MRNA Profile
- View Questions on MRNA

Q: I am building a diversified portfolio of healthcare stocks. I own JNJ, AMGN, MDT, CVS and MRNA. These are 2.9%, 3.8%, 2.5%, 4% and 0.5% of my portfolio respectively. Is this a high quality portfolio? Would you recommend any changes?

Read Answer Asked by David on October 08, 2025

Amgen Inc. (AMGN $295.32)
- $295.32 P/E (TTM): 24.15X Cap: $158.61B
- View AMGN Profile
- View Questions on AMGN
PayPal Holdings Inc. (PYPL $75.68)
- $75.68 P/E (TTM): 16.01X Cap: $72.73B
- View PYPL Profile
- View Questions on PYPL
AbbVie Inc. (ABBV $231.26)
- $231.26 P/E (TTM): 111.4X Cap: $408.49B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $852.42)
- $852.42 P/E (TTM): 55.14X Cap: $800.43B
- View LLY Profile
- View Questions on LLY
Progressive Corporation (The) (PGR $242.25)
- $242.25 P/E (TTM): 13.74X Cap: $142.48B
- View PGR Profile
- View Questions on PGR
Prologis Inc. (PLD $114.67)
- $114.67 P/E (TTM): 31.34X Cap: $107.64B
- View PLD Profile
- View Questions on PLD
Moderna Inc. (MRNA $27.63)
- $27.63 Cap: $10.86B
- View MRNA Profile
- View Questions on MRNA
Enphase Energy Inc. (ENPH $36.66)
- $36.66 P/E (TTM): 28.12X Cap: $4.71B
- View ENPH Profile
- View Questions on ENPH
BioNTech SE (BNTX $104.20)
- $104.20 Cap: $25.50B
- View BNTX Profile
- View Questions on BNTX

Q: Given the potential for a market down-turn, do you see any of these as a good buy for a long-term investment?

Read Answer Asked by Camille on August 01, 2025

Abbott Laboratories (ABT $133.27)
- $133.27 P/E (TTM): 16.69X Cap: $233.69B
- View ABT Profile
- View Questions on ABT
Eli Lilly and Company (LLY $852.42)
- $852.42 P/E (TTM): 55.14X Cap: $800.43B
- View LLY Profile
- View Questions on LLY
Pfizer Inc. (PFE $25.24)
- $25.24 P/E (TTM): 13.97X Cap: $146B
- View PFE Profile
- View Questions on PFE
Novo Nordisk A/S (NVO $58.66)
- $58.66 P/E (TTM): 16.59X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Moderna Inc. (MRNA $27.63)
- $27.63 Cap: $10.86B
- View MRNA Profile
- View Questions on MRNA

Q: Hello,

Given the current price levels of both MRNA and PFE would this be a good time to take position in either one of those? If so which one would you recommend.

Thank you!

Read Answer Asked by Irek on February 14, 2025